Weiss Ratings reiterated their sell (e+) rating on shares of 111 (NASDAQ:YI – Free Report) in a research note released on Saturday,Weiss Ratings reports.
111 Trading Down 0.7 %
NASDAQ YI traded down $0.00 during trading on Friday, reaching $0.43. 436,991 shares of the company’s stock were exchanged, compared to its average volume of 265,025. The firm has a market capitalization of $36.39 million, a PE ratio of -1.06 and a beta of 0.43. 111 has a fifty-two week low of $0.41 and a fifty-two week high of $1.60. The company’s fifty day simple moving average is $0.68 and its 200-day simple moving average is $0.82.
111’s stock is set to reverse split before the market opens on Friday, January 24th. The 1-10 reverse split was announced on Wednesday, January 8th. The number of shares owned by shareholders will be adjusted after the market closes on Thursday, January 23rd.
About 111
111, Inc engages in the provision of pharmaceutical products and medical services through online retail pharmacy and indirectly through offline pharmacy network. It operates through the B2C and B2B segments. The B2C segment engages in the sale of pharmaceutical and other health and wellness products directly to consumers through 1 Drugstore and its offline pharmacies.
Recommended Stories
- Five stocks we like better than 111
- Diversification Can Smooth Returns And Mitigate Portfolio Risk
- Earn High Dividends With 2 Top REITs Set to Perform in 2025
- Trading Halts Explained
- Oilfield Leader SLB: An AI Name You Need to Know
- How the NYSE and NASDAQ are Different, Why That Matters to Investors
- Top ETFs That Beat the Market in 2024 and Could Do It Again
Receive News & Ratings for 111 Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for 111 and related companies with MarketBeat.com's FREE daily email newsletter.
